Tunisian ‘Cure Bionics,’ chosen to receive funding from pan-African ‘Investing in Innovation’ program.

Cure Bionics, a Tunisian startup that creates bionic arms (prostheses) using 3D printing technology, has been chosen to receive funding from the pan-African Investing in Innovation (i3) programme, supported by the Gates Foundation, along with 29 other top African startups that have an impact on the healthcare supply chain. The business is also creating therapeutic applications for persons with disabilities utilizing immersive technologies, enabling them to receive care without having to visit a clinic.

The Bill & Melinda Gates Foundation-funded i3 program seeks to invest in the most promising African entrepreneurs that are either reshaping the healthcare supply chain or are still in their early phases.

A $50,000 grant and assistance will be provided to selected companies to help them forge growth-oriented alliances with institutions, business titans, and donors.

The 30 chosen firms are from 14 different nations throughout Africa. Authentication, traceability, inventory management, distribution of drugs and medical equipment, and medical waste management are just a few of the unique problems that these start-ups and expanding businesses address.

They show how African-designed solutions are ready to change access to healthcare supplies in a variety of ways. 30% of businesses operate in Francophone Africa, and 47% of company executives are female.

i3 is coordinated by Salient Advisory, SCIDaR and SouthBridge A&I and is implemented by the continent’s leading technology hubs: CcHUB for West Africa, Startupbootcamp Afritech for Southern Africa, IMPACT Lab for North and Francophone Africa, and Villgro Africa for East Africa. These hubs are responsible for the selection process and monitoring of startups throughout the programme.


Related posts